{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:52:43Z","timestamp":1759341163850},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s11934-007-0041-5","type":"journal-article","created":{"date-parts":[[2007,9,10]],"date-time":"2007-09-10T09:27:21Z","timestamp":1189416441000},"page":"419-424","source":"Crossref","is-referenced-by-count":4,"title":["Repeated botulinum toxin injection for idiopathic overactive bladder: Will chemodenervation become a long-term solution?"],"prefix":"10.1007","volume":"8","author":[{"given":"Darius J.","family":"Unwala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paholo","family":"Barboglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo E.","family":"Gousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,11]]},"reference":[{"key":"41_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"W.F. Stewart","year":"2003","unstructured":"Stewart WF, van Rooyen JB, Cundiff GW, et al.: Prevalence and burden of overactive bladder in the United States. World J Urol 2003, 20:327\u2013336.","journal-title":"World J Urol"},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","volume":"326","author":"P. Herbison","year":"2003","unstructured":"Herbison P, Hay-Smith J, Ellis G, Moore K: Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 2003, 326:841\u2013844.","journal-title":"BMJ"},{"key":"41_CR3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.sc.3101033","volume":"38","author":"E. Chartier-Kastler","year":"2000","unstructured":"Chartier-Kastler E, Mongiat-Artus P, Bitker MO, et al.: Long-term results of augmentation cystoplasty in spinal cord injury patients. Spinal Cord 2000, 38:490\u2013494.","journal-title":"Spinal Cord"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A. Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ: Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 2006, 49:644\u2013650.","journal-title":"Eur Urol"},{"key":"41_CR5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2006.01.005","volume":"49","author":"C. Chapple","year":"2006","unstructured":"Chapple C, Patel A: Botulinum toxin: new mechanisms, new therapeutic directions? Eur Urol 2006, 49:606\u2013608.","journal-title":"Eur Urol"},{"key":"41_CR6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"D.D. Dykstra","year":"1988","unstructured":"Dykstra DD, Sidi AA, Scott AB, et al.: Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 1988, 139:919\u2013922.","journal-title":"J Urol"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","volume":"342","author":"B. Schurch","year":"2000","unstructured":"Schurch B, Schmid DM, Stohrer M: Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000, 342:665.","journal-title":"N Engl J Med"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","volume":"63","author":"D.E. Rapp","year":"2004","unstructured":"Rapp DE, Lucinoni A, Katz EE, et al.: Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 2004, 63:1071\u20131075.","journal-title":"Urology"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","volume":"176","author":"D.M. Schmid","year":"2006","unstructured":"Schmid DM, Saurmann P, Werner M, et al.: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 2006, 176:177\u2013185.","journal-title":"J Urol"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.urology.2005.02.002","volume":"66","author":"H.C. Kuo","year":"2005","unstructured":"Kuo HC: Clinical effects of suburothelial injection of botulinum A toxin on patients with non-neurogenic detrusor overactivity refractory to anticholinergics. Urol 2005, 66:94\u201398.","journal-title":"Urol"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.eururo.2005.06.021","volume":"48","author":"H. Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Stolze T, et al.: Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur Urol 2005, 48:984\u2013990.","journal-title":"Eur Urol"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.ju.0000169480.43557.31","volume":"174","author":"R. Popat","year":"2005","unstructured":"Popat R, Apostolidis A, Kalsi V, et al.: A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin. J Urol 2005, 174:984\u2013989.","journal-title":"J Urol"},{"key":"41_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B. Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P, et al.: Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005, 174:196\u2013200.","journal-title":"J Urol"},{"key":"41_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A. Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G, et al.: European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004, 45:510\u2013515.","journal-title":"Eur Urol"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","volume":"44","author":"T. Leippold","year":"2003","unstructured":"Leippold T, Reitz A, Schurch B: Botulinum toxin-A as a new therapy option for voiding disorders: current state of the art. Eur Urol 2003, 44:165\u201374.","journal-title":"Eur Urol"},{"key":"41_CR16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","volume":"47","author":"J. Grosse","year":"2005","unstructured":"Grosse J, Kramer G, St\u00f6hrer M: Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic overactivity and incontinence. Eur Urol 2005, 47:653\u2013659.","journal-title":"Eur Urol"},{"key":"41_CR17","unstructured":"Del Popolo G: Botulinum-A toxin in the treatment of detrusor hyperreflexia [abstract]. Presented at the 31st Annual Meeting of the International Continence Society. September 18\u201321, 2001; Seoul, Korea."},{"key":"41_CR18","unstructured":"Del Popolo G, Li Marzi V, Panariello G, Lombardi G: English botulinum toxin-A in the treatment of neurogenic detrusor overactivity [abstract 96]. Presented at the 33rd Annual Meeting of the International Continence Society. October 5\u20139, 2003; Florence, Italy."},{"key":"41_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","volume":"40","author":"J.J. Wyndaele","year":"2002","unstructured":"Wyndaele JJ, van Dromme SA: Muscular weakness as a side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 2002, 40:599\u2013600.","journal-title":"Spinal Cord"},{"key":"41_CR20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","volume":"63","author":"H.C. Kuo","year":"2004","unstructured":"Kuo HC: Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 2004, 63:868\u2013872.","journal-title":"Urology"},{"key":"41_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","volume":"24","author":"T.M. Kessler","year":"2005","unstructured":"Kessler TM, Danuser H, Schumacher M, et al.: Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 2005, 24:231\u2013236.","journal-title":"Neurourol Urodyn"},{"key":"41_CR22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","volume":"171","author":"A. Reitz","year":"2004","unstructured":"Reitz A, Schurch B: Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J Urol 2004, 171:804\u2013805.","journal-title":"J Urol"},{"key":"41_CR23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","volume":"171","author":"D. Pistolesi","year":"2004","unstructured":"Pistolesi D, Selli C, Rossi B, Stampacchia G. Botulinum toxin type B for type A resistant bladder spasticity. J Urol 2004, 171:802\u2013803.","journal-title":"J Urol"},{"key":"41_CR24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.urology.2007.01.030","volume":"69","author":"H. Schulte-Baukloh","year":"2007","unstructured":"Schulte-Baukloh H, Bigalke H, Heine G, et al.: Antibodies against botulinum neurotoxin type A as a cause of treatment failure after the first detrusor injection. Urology 2007, 69:575.","journal-title":"Urology"},{"key":"41_CR25","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","volume":"45","author":"J. Jankovic","year":"1995","unstructured":"Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 1995, 45:1743\u20131746.","journal-title":"Neurology"},{"key":"41_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/0929867053363315","volume":"12","author":"G. Maria","year":"2005","unstructured":"Maria G, Cadeddu F, Brisinda D, et al.: Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin. Curr Med Chem 2005, 12:247\u2013265.","journal-title":"Curr Med Chem"},{"key":"41_CR27","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","volume":"46","author":"A. Haferkamp","year":"2004","unstructured":"Haferkamp A, Schurch B, Reitz A, et al.: Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder. Eur Urol 2004, 46:784\u2013791.","journal-title":"Eur Urol"},{"key":"41_CR28","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.eururo.2006.01.025","volume":"50","author":"E. Comperat","year":"2006","unstructured":"Comperat E, Reitz A, Delcourt A, et al.: Histologic features in the urinary bladder wall affected from neurogenic overactivity: a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A. Eur Urol 2006, 50:1058\u20131064.","journal-title":"Eur Urol"},{"key":"41_CR29","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.ajog.2004.11.052","volume":"192","author":"M. Werner","year":"2005","unstructured":"Werner M, Schmid DM, Schussler B. Efficacy of botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 2005, 192:1735\u20131740.","journal-title":"Am J Obstet Gynecol"},{"key":"41_CR30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2006.08.1069","volume":"68","author":"G. Karsenty","year":"2006","unstructured":"Karsenty G, Reitz A, Lindemann G, et al.: Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology 2006, 68:1193\u20131197.","journal-title":"Urology"},{"key":"41_CR31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.urology.2005.05.054","volume":"66","author":"H. Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Knispel HH, Stolze T, et al.: Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity. Urology 2005, 66:865\u2013870.","journal-title":"Urology"},{"key":"41_CR32","first-page":"39","volume":"177","author":"A.E. Gousse","year":"2007","unstructured":"Gousse AE, Cohen B, Rodriguez D, Barboglio PG: Scheduled repeated Botox injections for idiopathic OAB: evaluating therapeutic time. J Urol 2007, 177:39.","journal-title":"J Urol"},{"key":"41_CR33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","volume":"49","author":"V. Kalsi","year":"2006","unstructured":"Kalsi V, Popat RB, Apostolidis A, et al.: Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 2006, 49:519\u2013527.","journal-title":"Eur Urol"},{"key":"41_CR34","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","volume":"63","author":"H.C. Kuo","year":"2004","unstructured":"Kuo HC: Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 2004, 63:868.","journal-title":"Urology"},{"key":"41_CR35","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/end.2005.19.880","volume":"19","author":"C.P. Smith","year":"2005","unstructured":"Smith CP, Chancellor MB: Simplified bladder botulinumtoxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol 2005, 19:880\u2013882.","journal-title":"J Endourol"},{"key":"41_CR36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.juro.2006.10.050","volume":"177","author":"B.L. Cohen","year":"2007","unstructured":"Cohen BL, Rivera R, Barboglio P, Gousse A. Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection. J Urol 2007, 177:1006\u20131010.","journal-title":"J Urol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-007-0041-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-007-0041-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-007-0041-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T12:27:53Z","timestamp":1587904073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-007-0041-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s11934-007-0041-5","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}